US FDA To Publish Advisory Committee Timeline For COVID-19 Vaccine In Children Under 5

But CBER Director Peter Marks reiterated to Senators that EUAs cannot be granted for those children until applications are completed and submitted.

FDA officials at Senate HELP hearing on user fee reauthorization
CDER Director Patrizia Cavazzoni, CBER Director Peter Marks, and CDRH Director Jeffrey Shuren testify during a Senate Health, Education, Labor and Pensions Committee hearing on the user fee program reauthorizations. • Source: Screenshot

More from Vaccines

More from Pink Sheet